MARETTI, ELEONORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.459
AS - Asia 4.787
EU - Europa 4.249
SA - Sud America 712
Continente sconosciuto - Info sul continente non disponibili 250
AF - Africa 105
OC - Oceania 49
Totale 18.611
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.253
SG - Singapore 1.432
IT - Italia 1.194
CN - Cina 1.153
GB - Regno Unito 1.139
VN - Vietnam 621
BR - Brasile 553
HK - Hong Kong 538
SE - Svezia 495
DE - Germania 311
BD - Bangladesh 235
FR - Francia 212
RU - Federazione Russa 196
FI - Finlandia 173
IN - India 170
KR - Corea 137
UA - Ucraina 125
CA - Canada 107
TR - Turchia 95
ID - Indonesia 70
NL - Olanda 67
BG - Bulgaria 65
AR - Argentina 63
BE - Belgio 63
JP - Giappone 62
MX - Messico 51
PL - Polonia 42
AU - Australia 39
IQ - Iraq 37
PK - Pakistan 31
IR - Iran 28
EC - Ecuador 24
ES - Italia 24
ZA - Sudafrica 24
LT - Lituania 23
AE - Emirati Arabi Uniti 20
PH - Filippine 20
CL - Cile 19
CO - Colombia 19
IE - Irlanda 19
MY - Malesia 17
KE - Kenya 16
MA - Marocco 14
VE - Venezuela 13
AZ - Azerbaigian 12
TW - Taiwan 12
UZ - Uzbekistan 12
JM - Giamaica 11
TH - Thailandia 11
AT - Austria 10
EG - Egitto 10
NP - Nepal 10
NZ - Nuova Zelanda 10
TN - Tunisia 10
CZ - Repubblica Ceca 9
IL - Israele 9
JO - Giordania 9
RS - Serbia 9
CH - Svizzera 8
PE - Perù 8
RO - Romania 8
CR - Costa Rica 7
HU - Ungheria 7
PT - Portogallo 7
PY - Paraguay 7
GR - Grecia 6
KZ - Kazakistan 6
MD - Moldavia 6
SA - Arabia Saudita 6
BY - Bielorussia 5
DK - Danimarca 5
DZ - Algeria 5
GE - Georgia 5
GT - Guatemala 5
BB - Barbados 4
EE - Estonia 4
EU - Europa 4
HR - Croazia 4
LK - Sri Lanka 4
LV - Lettonia 4
NG - Nigeria 4
SC - Seychelles 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
AL - Albania 3
BO - Bolivia 3
CI - Costa d'Avorio 3
HN - Honduras 3
LB - Libano 3
ML - Mali 3
MN - Mongolia 3
PA - Panama 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
BH - Bahrain 2
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
KG - Kirghizistan 2
KW - Kuwait 2
Totale 18.336
Salva come PNG Salva come JPEG
Città #
Singapore 920
Santa Clara 844
Ashburn 823
Southend 721
Fairfield 571
Chandler 541
San Jose 521
Hong Kong 519
Woodbridge 356
Council Bluffs 311
Nyköping 257
Hefei 249
Beijing 241
Dearborn 240
Houston 234
Ann Arbor 225
Wilmington 217
Modena 210
Jacksonville 208
Ho Chi Minh City 196
Seattle 191
London 179
Cambridge 176
Hanoi 153
Los Angeles 149
The Dalles 127
Helsinki 126
New York 124
Seoul 120
Milan 101
Columbus 66
Princeton 62
Moscow 60
Lauterbourg 58
Sofia 58
San Diego 54
Bremen 53
Redwood City 51
Buffalo 50
Frankfurt am Main 50
Eugene 48
Shanghai 45
Dallas 44
Fremont 43
São Paulo 42
Rome 41
Izmir 40
Chicago 39
Tokyo 39
Da Nang 38
Bologna 37
Brussels 36
Jakarta 36
Ottawa 33
Warsaw 33
Orem 31
Munich 30
Phoenix 26
Atlanta 24
Chennai 24
Haiphong 24
Mumbai 23
Formigine 22
Mexico City 22
Naples 22
Parma 22
Porto Alegre 22
Rio de Janeiro 22
Montreal 21
Basingstoke 20
Denver 20
Amsterdam 19
Boardman 19
Sydney 19
Falls Church 18
Guangzhou 18
San Francisco 17
Hangzhou 15
New Delhi 15
Charlotte 14
Johannesburg 14
Boston 13
Brooklyn 13
Dublin 13
Nanjing 13
Napoli 13
Quito 13
Reggio Nell'emilia 13
Toronto 13
Washington 13
Belo Horizonte 12
Kunming 12
La Puente 12
Lappeenranta 12
Nairobi 12
Nuremberg 12
Baghdad 11
Dhaka 11
Gurgaon 11
Hyderabad 11
Totale 11.782
Salva come PNG Salva come JPEG
Nome #
The Impact of Lipid Corona on Rifampicin Intramacrophagic Transport Using Inhaled Solid Lipid Nanoparticles Surface-Decorated with a Mannosylated Surfactant 419
Conveying a newly designed hydrophilic anti-human thymidylate synthase peptide to cisplatin resistant cancer cells: are pH-sensitive liposomes more effective than conventional ones? 405
Enhanced anti-hyperproliferative activity of human thymidylate synthase inhibitor peptide by solid lipid nanoparticle delivery 404
Characterization of natural clays from italian deposits with focus on elemental composition and exchange estimated by edx analysis: potential pharmaceutical and cosmetic uses 389
Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis 384
pH-Promoted Release of a Novel Anti-Tumour Peptide by “Stealth” Liposomes: Effect of Nanocarriers on the Drug Activity in Cis-Platinum Resistant Cancer Cells 380
Gastroretentive montmorillonite-tetracycline nanoclay for the treatment of Helicobacter pylori infection 379
Surface engineering of Solid Lipid Nanoparticle assemblies by methyl α-d-mannopyranoside for the active targeting to macrophages in anti-tuberculosis inhalation therapy 363
Organo-modified bentonite for gentamicin topical application: interlayer structure and in vivo skin permeation 362
A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells 357
Application of the "in-oil nanoprecipitation" method in the encapsulation of hydrophilic drugs in PLGA nanoparticles 344
Anti-TB inhalation therapy: Design of mannose-based functionalised Solid Lipid Microparticles for an active targeting to alveolar macrophages 344
Self-Assembled Lipid Nanoparticles for Oral Delivery of Heparin-Coated Iron Oxide Nanoparticles for Theranostic Purposes 339
In vivo silica nanoparticle translocation across human stratum corneum: the effect of surface hydrophobization in relation to hair follicle density. 334
In vivo penetration of bare and lipid-coated silica nanoparticles across the human stratum corneum 333
Polymeric and Solid Lipid Nanoparticles for nose-to-brain delivery of geraniolursodeoxycholic acid conjugate: development and characterization studies 326
Novel engineered lipid-based nanoparticles for pulmonary tuberculosis inhalation therapy 321
DEVELOPMENT AND COMPARISON OF TWO LIPID-BASED NANOSYSTEMS FOR THE CO-DELIVERY OF RIFAMPICIN AND ISONIAZID: SMALL-ANGLE NEUTRON SCATTERING CHARACTERISATION 312
Solid Lipid Nanoparticle assemblies (SLNas) for an anti-TB inhalation treatment-A Design of Experiments approach to investigate the influence of pre-freezing conditions on the powder respirability 309
In vitro behaviour of hybrid lipid/chitosan nanoparticles for the oral delivery of heparin 300
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery 293
Design, Characterization, and In Vitro Assays on Muscle Cells of Endocannabinoid-like Molecule Loaded Lipid Nanoparticles for a Therapeutic Anti-Inflammatory Approach to Sarcopenia 288
pH sensitive PEGylated Liposomes delivering active hydrophilic peptide with anticancer activity: in vitro study on cDDP-resistant ovarian cell line 286
Small-angle neutron scattering characterization of liposomes for anti-tuberculosis inhaled therapy. 282
Nanoencapsulation of an hTS inhibitor octapeptide against ovarian cancer in solid lipid matrix 277
In Vivo Biodistribution of Respirable Solid Lipid Nanoparticles Surface-Decorated with a Mannose-Based Surfactant: A Promising Tool for Pulmonary Tuberculosis Treatment? 277
SOLID LIPID MICROPARTICLES FOR INHALED ANTI-TB THERAPY BY DPI: INFLUENCE OF THE PRODUCTION PROCESS ON DRUG STABILITY AND POWDER BREATHABILITY 267
Self-assembled organogelators as artificial stratum corneum models: key-role parameters for skin permeation prediction 267
Lipid-based microparticles for TB inhaled therapy: physical properties and cell internalization 266
Drugs/lamellae interface influences the inner structure of double-loaded liposomes for inhaled anti-TB therapy: An in-depth small-angle neutron scattering investigation 262
Formulazione per veicolare principi attivi lipofili 260
SURFACE ENGINEERING OF SOLID LIPID NANOASSEMBLIES FOR INHALED INTRAMACROPHAGIC ANTI-TB THERAPY 260
Aerodynamic performance of lipid-based nanocarrier functionalized by novel mannose derivatives for Rifampicin intramacrophagic delivery 259
Development and in vitro characterization of SLN encapsulating magnetic Heparin coated Iron Oxide for theranostic application 258
Self-assembling organogelators for artificial stratum corneum models: key-role parameters in skin permeation prediction 252
Inhaled SLM for anti-TB therapy by DPI device: process parameters affecting freeze-drying and breathability 250
In vitro evaluation on CaCo-2 cells of hybrid lipid/chitosan nanoparticles for the oral delivery of heparin. 247
Development of lipid nanocarriers as delivery systems for a small peptide with anti-ovarian activity 246
Chitosan/heparin polyelectrolyte complexes as ion-paring approach to encapsulate heparin in orally administrable SLN: In vitro evaluation 234
Metodo per modulare l'assorbimento fagocitario di un principio attivo o un suo precursore da parte di macrofagi 232
Tetracycline-Montmorillonite nanoclay for the treatment of H. pylori infection 232
Inhalated drug delivery systems to target alveolar macrophages for tuberculosis therapy: design of safe SLM loaded with rifampicin 231
PROGETTAZIONE E OTTIMIZZAZIONE DI SISTEMI MICROPARTICELLARI PER LA VEICOLAZIONE AI MACROFAGI ALVEOLARI DI FARMACI ANTITUBERCOLARI PER VIA INALATORIA 228
Nasal administration of nanoencapsulated geraniol/ursodeoxycholic acid conjugate: Towards a new approach for the management of Parkinson's disease 221
Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy 215
Formulazione per veicolare principi attivi lipofili 214
PASSIVE AND ACTIVE TARGETING TO MACROPHAGES USING LIPID NANOPARTICLES ASSEMBLIES FOR ANTI-TB THERAPY BY PULMONARY ROUTE 203
Nuove molecole funzionalizzanti per il targeting ai macrofagi di vettori lipidici 197
Development of solid lipid nanoparticles for the delivery of an anti- inflammatory drug to muscle skeletal cells 194
Medicinal Chemistry drives drug targeted delivery: a successful interplay 192
The improvement of Solid Lipid Microparticle breathability for an anti-TB inhalation therapy 188
In vivo β-carotene skin permeation modulated by Nanostructured Lipid Carriers 188
Epitranscriptomics as a New Layer of Regulation of Gene Expression in Skeletal Muscle: Known Functions and Future Perspectives 186
Nasal biocompatible powder of geraniol oil complexed with cyclodextrins for neurodegenerative diseases: Physicochemical characterization and in vivo evidences of nose to brain delivery 183
Inhaled micro- or nanoparticles: which are the best for intramacrophagic anti-infectious therapies? 175
Solid Lipid Microparticles for inhaled anti-TB therapy by DPI: influence of the production process on drug stability and powder breathability 171
Combination of Nanodelivery Systems and Constituents Derived from Novel Foods: A Comprehensive Review 166
Inflammatory-Targeted Lipid Carrier as a New Nanomaterial to Formulate an Inhaled Drug Delivery System 166
Linking endocannabinoid system, palmitoylethanolamide, and sarcopenia in view of therapeutic implications 166
Design and physicochemical characterization of novel hybrid SLN-liposome nanocarriers for the smart co-delivery of two antitubercular drugs 164
Palmitoylethanolamide-loaded Solid Lipid Nanoparticles for a therapeutic anti-inflammatory approach of Sarcopenia involving ECS 154
APPLICATION OF A NEW SURFACTANT FOR INHALED ANTI-INFLAMMATORY DRUG DELIVERY SYSTEMS: FROM NANOCARRIER TO PURE NANODRUG FORMULATION 153
Dispositivo per la somministrazione intravaginale di batteri e loro metaboliti 147
Plant Resin Delivery by Nanovectors as an Emerging Approach to Boost Solubility, Permeability and Bioavailability 145
Nanoparticulate systems for the delivery of Palmitoylethanolamide to muscle cells 144
Investigating hybrid lipid-PLGA nanoparticles loaded with an endogenous endocannabinoid-like molecule for targeting inflamed muscle 131
Optimizing Formulation Conditions of PLGA Microparticles to Enhance Indomethacin Encapsulation 124
Inhaled lipid nanoparticles: a feasible tool for a challenging route 118
IMMOBILIZATION OF HEPARIN BY TERNARY POLYELECTROLYTE COMPLEXES: A PRELIMINARY STUDY 109
Lipid Nanodrugs for topical anti-inflammatory treatment of psoriasis: in vivo studies 106
New insights on Indomethacin and PLGA interaction for a rational design of microparticles to be administered via intra-articular route 104
Physicochemical characterization of SLN/Liposomes hybrid nanoparticles for the co-delivery of two antitubercular drugs: focus on SANS analysis 100
ENGINEERING OF DRUG DELIVERY SYSTEMS TO ENHANCE DRUG POTENTIAL: FROM BEADS TO POLYMER-FREE NANOPARTICLES 99
Design and development of hybrid plga nanoparticles for the co-delivery of trimetazidine and palmitoylethanolamide for the treatment of sarcopenia 99
Investigating Hybrid PLGA-Lipid Nanoparticles as an Innovative Delivery Tool for Palmitoylethanolamide to Muscle Cells 97
Nanoparticle-mediated delivery to skeletal muscle cells of N-palmitoylethanolamide (PEA), an endocannabinoid-like molecule with anti-inflammatory properties 86
Comparative in vitro study of lipid and polymeric nanoparticles for the delivery of PEA to myoblasts. 84
Polymeric nanoparticles as a favorable delivery system to enhance the anti-inflammatory action of N-palmitoylethanolamide (PEA), an endocannabinoid-like molecule 77
Development of a Heparin-Loaded Polyelectrolyte Complex for pH-Responsive Wound Healing Applications 76
Targeted Nanodrugs for Inhaled Therapy of Inflammatory Lung diseases 60
Smart nanodelivery of palmitoylethanolamide for topical treatment of inflammatory skin diseases 35
Anti-inflammatory endocannabinoid-like molecule for topical and pulmonary administration: comparison between two different nano-delivery systems 24
ENGINEERING A NANO‑OLEOGEL SYSTEM TO ENHANCE ORAL ADMINISTRATION OF PEA FOR ANTI‑INFLAMMATORY APPLICATIONS 23
MULTIFUNCTIONAL HYBRID LIPID-PLGA NANOPARTICLES FOR DUAL DRUG DE-LIVERY: SURFACE FUNCTIONALIZATION WITH M12 PEPTIDE FOR MUSCLE TAR-GETING 16
Device for the intravaginal administration of bacteria and their metabolites 14
Dual-Modulated Heparin Delivery from Electrospun PVA Nanofibers for Wound Healing: The Role of Polyelectrolyte Complexes and Fiber Crosslinking 12
Dual‑loaded nanoparticles targeting inflammation as multimodal strategy against sarcopenia 11
In vitro study emulating muscle response to stimuli exploiting 3D tissue model 9
Design of a new drug delivery system for the treatment of skin inflammatory diseases: smart delivery of palmitoylethanolamide 7
Totale 18.611
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.903
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.903
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.198 0 0 119 59 55 123 50 88 180 120 276 128
2022/20231.475 222 205 105 172 162 171 29 143 148 24 59 35
2023/2024863 34 67 69 94 174 106 70 74 18 28 50 79
2024/20253.311 78 30 118 227 601 429 311 249 359 156 342 411
2025/20266.021 389 199 432 559 785 388 914 388 671 644 374 278
2026/20271.060 206 631 223 0 0 0 0 0 0 0 0 0
Totale 18.611